Market Cap 6.66B
Revenue (ttm) 4.05B
Net Income (ttm) 22.20M
EPS (ttm) N/A
PE Ratio 13.25
Forward PE 14.36
Profit Margin 0.55%
Debt to Equity Ratio 0.78
Volume 654,100
Avg Vol 1,766,284
Day's Range N/A - N/A
Shares Out 49.12M
Stochastic %K 22%
Beta 1.50
Analysts Sell
Price Target $158.64

Latest News on CRL

Charles River Introduces Global Biotech Incubator Program

Dec 5, 2024, 8:00 AM EST - 6 months ago

Charles River Introduces Global Biotech Incubator Program


Charles River Laboratories Announces Third-Quarter 2024 Results

Nov 6, 2024, 7:00 AM EST - 7 months ago

Charles River Laboratories Announces Third-Quarter 2024 Results